| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 03/04/2009 | CN101379065A Imidazopyridine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same |
| 03/04/2009 | CN101379041A Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 03/04/2009 | CN101376109A Sodium-molybdenum series composite catalyst for synthesizing copper phthalocyanine |
| 03/03/2009 | US7498444 (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate |
| 03/03/2009 | US7498434 e.g. N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylpropanamide; reacting aminopyrazole compound with substituted 1-oxo-2-propenyl-arene(-heterocycle) under acidic conditions in reaction medium (two-phase mixture of aqueous solution and water-immiscible organic liquid); anxiolytic agent |
| 03/03/2009 | US7498432 Method of synthesis of 1, 4, 7, 10, 13, 16, 21, 24-octaazabicyclo [8.8.8] hexacosane (1) and 1, 4, 7, 10, 13, 16, 21, 24-octaazabicyclo [8.8.8] hexacosa, 4, 6, 13, 15, 21, 23-hexaene (2) |
| 03/03/2009 | US7498336 anticancer agents; to regulate p53 and MDM2 stability and activity; 10-(3-chloro-phenyl)-7-nitro-10H-pyrimido[4,5-b]quinoline-2,4-dione, and 10-(4-chloro-phenyl)-7-nitro-10H-pyrimido[4,5-b]quinoline-2,4-dione |
| 03/03/2009 | US7498335 Method of producing an antiangiogenic or vascular permeability reducing effect |
| 03/03/2009 | US7498334 Pyrrolopyrimidines as phosphodiesterase VII inhibitors |
| 03/03/2009 | US7498332 Therapy for cerebral vasospasm |
| 03/03/2009 | US7498330 4-oxo-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds |
| 03/03/2009 | US7498323 Spiro-piperidine compounds and medicinal use thereof |
| 03/03/2009 | US7498302 Analogues of rachelmycin and the duocarmycins that are potent cytotoxins containing a benzodipyrrole or naphthopyrrole ring; anticancer agents |
| 03/03/2009 | CA2258165C N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 02/26/2009 | WO2009026446A2 Hdac inhibitors |
| 02/26/2009 | WO2009026326A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | WO2009026319A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | WO2009026241A1 Heterocyclic modulators of tgr5 |
| 02/26/2009 | WO2009026107A1 Protein kinase inhibitors |
| 02/26/2009 | WO2009025265A1 Piperazine derivative |
| 02/26/2009 | WO2009024824A1 2-anilinopurin-8-ones as inhibitors of ttk/mps1 for the treatment of proliferative disorders |
| 02/26/2009 | WO2009024585A2 Imidazo [1,2-a] pyrazine compounds for treatment of viral infections such as hepatitis |
| 02/26/2009 | WO2009024502A1 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/26/2009 | WO2009023978A1 Pyrazolo [3,4 -d] pyrimidine compounds and their use as modulators of protein kinase |
| 02/26/2009 | WO2008157207A3 Metabolites of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-lh-pyrazol-l-yl)-3- cyclopentylpropanenitrile |
| 02/26/2009 | WO2008155339A3 Labelling methods |
| 02/26/2009 | WO2008138551A3 3-(2-alkoxy-phenyl)-substituted tetramates |
| 02/26/2009 | WO2008094222A3 Porphyrin catalysts and methods of use thereof |
| 02/26/2009 | WO2008030579A3 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 02/26/2009 | US20090054480 Novel quinuclidine carbamate derivatives and medicinal compositions containing the same |
| 02/26/2009 | US20090054472 Pyrazolopyrimidine Derivatives or Pharmaceutically Acceptable Salts Thereof |
| 02/26/2009 | US20090054467 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases |
| 02/26/2009 | US20090054451 Use of Piperidine Derivatives as Agonists of Chemokine Receptor Activity |
| 02/26/2009 | US20090054446 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists |
| 02/26/2009 | US20090054441 Process For The Preparation of an Optically Active 5H-Pyrrolo [3,4-B] Pyrazine Derivative |
| 02/26/2009 | US20090054440 Quinoline derivatives as neurokinin receptor antagonists |
| 02/26/2009 | US20090054425 Protein kinase inhibitors |
| 02/26/2009 | US20090054416 1,4-Diazabicyclo[3.2.2]nonanecarboxamide Derivatives, Preparation and Therapeutic Use Thereof |
| 02/26/2009 | US20090054413 Novel 5,6-Dihydropyrazolo[3,4-E] [L,4]Diazepin-4 (IH) -One Derivatives for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease |
| 02/26/2009 | US20090054397 Pyrazole compounds and pharmaceutical compositions comprising the compound |
| 02/26/2009 | US20090054304 Heterocyclic modulators of tgr5 for treatment of disease |
| 02/26/2009 | CA2707521A1 Imidazopyrazine compounds |
| 02/26/2009 | CA2697325A1 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/26/2009 | CA2697100A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | CA2696631A1 Heterocycles as potassium channel modulators |
| 02/26/2009 | CA2696200A1 2-anilinopurin-8-ones as inhibitors of ttk/mps1 for the treatment of proliferative disorders |
| 02/26/2009 | CA2695452A1 Hdac inhibitors |
| 02/25/2009 | EP2027129A2 Fused heterocylic compounds and their use as mglur5 modulators |
| 02/25/2009 | EP2027128A2 Fused heterocylic compounds and their use as mglur5 modulators |
| 02/25/2009 | EP2027127A1 Pyrazolo [1, 5-a]pyrimidines as cdk inhibitors |
| 02/25/2009 | EP2027126A2 Crystalline forms of 5-chloro-6- (2, 6-difluoro-4-[3- (methylamino) propoxy] phenyl)-n-((1s)-2, 2, 2,-trifluoro-1-methylethyl][1,2,4]triazolo [1,5-a]pyrimidin-7-amine salts |
| 02/25/2009 | EP2027125A1 Pentacyclic indole derivatives as antiviral agents |
| 02/25/2009 | EP2027124A1 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| 02/25/2009 | EP2026811A1 Pyrazolo [3, 4-d]pyrimidine derivatives useful to treat respiratory disorders |
| 02/25/2009 | EP1692135A4 A new process for preparation of imipenem |
| 02/25/2009 | EP1644379A4 Rotaxane compound, rotaxane-bonded solid substrate, and biochip using the same |
| 02/25/2009 | EP1641801B9 Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors |
| 02/25/2009 | CN101374846A Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |
| 02/25/2009 | CN101374845A Novel compounds and use thereof |
| 02/25/2009 | CN101374844A Pyrrolopyridazinone compound |
| 02/25/2009 | CN101374843A Triazolopyridazines as tyrosine kinase modulators |
| 02/25/2009 | CN101374842A Azepinoindole derivatives as pharmaceutical agents |
| 02/25/2009 | CN101374813A Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders |
| 02/25/2009 | CN100463908C Substituted 8' -pyridinyl-dihydrospiro- [cycloalkyl] -pyrimido [1,2-a] pyrimidin-6-one and 8' -pyrimidinyl-dihydrospiro- [cycloalky]l -pyrimido p1,2-a] pyrimidin-6-one derivatives |
| 02/25/2009 | CN100463720C Phase-transferring catalyst containing dinaphthalene chiral double-spiral quaternary ammonium and its production method |
| 02/24/2009 | US7495123 useful in the asymmetric synthesis of biologically active molecules; enantioselective hydrogenation of an amine-unprotected prochiral beta-amino acrylic acid or derivative thereof in the presence of a rhodium metal precursor complexed with a chiral mono- or bisphosphine ligand |
| 02/24/2009 | US7495112 Isoindoline compounds and methods of making and using the same |
| 02/24/2009 | US7495096 Processes for the production of chinazoline alkaloids |
| 02/24/2009 | US7495014 Gyrase inhibitors and uses thereof |
| 02/24/2009 | US7494996 can be applied as sprays by methods commonly employed in crops such as vegetables, fruits, ornamentals, seeds, turf, cereal and vines among other plants |
| 02/24/2009 | US7494993 Enhanced activity, decreased toxicity, better solubility and improved pharmacokinetic profile; for inflammatory, immunological, CNS disorders, oncological disorders, bone diseases; Cyclohexanecarboxylic acid (4-chloro-3-{7-amino-1-methyl-2-oxo-1,4-dihydro-2H-pyrimido[4,5-d]pyrimidin-3-yl}-phenyl)-amide |
| 02/24/2009 | US7494984 Substituted imidazo[1,2-a]pyrimidines as HIV viral DNA integrase inhibitors |
| 02/24/2009 | CA2471338C Use of deoxypeganine for treating clinical depression |
| 02/24/2009 | CA2444208C Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same |
| 02/24/2009 | CA2432085C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 02/24/2009 | CA2297406C Tricyclic vasopressin agonists |
| 02/24/2009 | CA2247820C Functionalized nanotubes |
| 02/19/2009 | WO2009023623A1 Heteroaryl amide analogues |
| 02/19/2009 | WO2009023487A1 Tetracyclic compounds for the treatment of hepatitis c |
| 02/19/2009 | WO2009023402A2 Heterocyclic compounds and uses as anticancer agents |
| 02/19/2009 | WO2009023269A2 4-(9-(3, 3-difluorocyclopentyl) -5, 7, 7-trimethyl-6-oxo-6, 7, 8, 9-tetrahydro-5h-pyrimido [4, 5-b[1, 4] diazepin-2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases plk1 to plk4 for the treatment of proliferative diseases |
| 02/19/2009 | WO2009023181A1 6-SUBSTITUTED SULFONYL AZABICYCLO[3.2.1]OCTANES USEFUL TO INHIBIT 11β-HYDROXYSTEROID DEHYDROGENASE TYPE-1 |
| 02/19/2009 | WO2009023179A2 Nitrogen containing bicyclic chemical entities for treating viral infections |
| 02/19/2009 | WO2009021992A2 Fused bicyclic pyrimidines |
| 02/19/2009 | WO2009021990A1 Fused imidazoles for cancer treatment |
| 02/19/2009 | WO2009021869A1 Pyrazolo[3,4-d]-pyramidine derivatives as antiproliferative agents |
| 02/19/2009 | US20090048444 Process for Preparing Pyrido[2,3-d]pyrimidin-7-one and 3,4-Dihydropyrimido[4,5-d]pyrimidin-2(1H)-one Derivatives |
| 02/19/2009 | US20090048442 Novel compounds |
| 02/19/2009 | US20090048274 PYRAZOLO[3,4-d]PYRIMIDINE DERIVATIVES |
| 02/19/2009 | US20090048271 Heterocyclic compounds and uses as anticancer agents |
| 02/19/2009 | US20090048244 Pyrrolotriazine compounds as kinase inhibitors |
| 02/19/2009 | US20090048239 Therapeutic compounds |
| 02/19/2009 | US20090048236 New phenylalanine derivatives |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | US20090048223 Sulfonamide compound |
| 02/19/2009 | US20090047692 Optically-detectable enzyme substrates and their method of use |
| 02/19/2009 | US20090047306 Adjuvant compositions |
| 02/19/2009 | US20090047252 Antiviral compounds |
| 02/19/2009 | US20090047248 Triazolyl macrocyclic hepatitis c serine protease inhibitors |
| 02/19/2009 | US20090044348 3-amino-2-{[(1E)-2-amino-5-methyl-4-oxocyclohexa-2,5-dien-1-ylidene]amino}-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one; 3-amino-4-[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl) imino]cyclohexa-2,5-dien-1-ylidene}-N-methylmethanaminium perchlorate for coloring keratin fibers; leuco dye |